Waltham MA – According to filings with the U.S. Securities and Exchange Commission, Viridian LLC is raising $5,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Jonathan Violin played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Viridian LLC

At Viridian our goal is to strengthen the link between scientific discovery and product commercialization. The proliferation of biomedical discoveries made by academic and industry scientists in recent decades has unlocked the potential to treat many previously intractable serious and life-threatening diseases. The biopharmaceutical industry, through both venture investment and biopharma R&D, has successfully translated many of these discoveries into approved medications. However, structural features of this ecosystem often leave the ultimate promise of many discoveries unfulfilled.

To learn more about Viridian LLC, visit http://www.viridianbio.com/

Contact:
Jonathan Violin, President and Chief Executive Officer
919-949-8552
https://www.linkedin.com/in/jonathan-violin-0a1bb21/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved